News
diabetic macular edema
Eylea HD receives approval for dosing interval extension
This updated dosing schedule means that wet AMD and DME patients can now have their treatment plans tailored to their individual needs.
diabetic macular edema
Eydenzelt receives FDA approval for four retinal diseases
Eydenzelt is approved for use in treating wet age-related macular degeneration, macular edema following reetinal vein occlusion, diabetic macular edema and diabetic retinopathy.
diabetic macular edema
Vitamin D deficiency linked to diabetic maculopathy
Researchers recently sought to determine the role vitamin D plays in the development of diabetic macular ischemia (DMI), which is an irreversible diabetic maculopathy.
bevacizumab
HIV drug improves vision for Diabetic Macular Edema patients
Researchers are hopeful that Iamivudine, an inexpensive, oral drug that has been used to treat HIV, may be a cost-effective and non-invasive therapy for patients.
diabetic macular edema
Regeneron receives FDA approval for EYLEA HD
The Food and Drug Administraton (FDA) gave approval after two active-controlled, double-masked pivotal trials, which compared EYLEA HD to EYLEA over a 48 week period.
diabetic macular edema
New type of eye drop may help treat retinal diseases
For patients suffering from blinding retinal diseases like diabetic macular edema, the only treatment options they currently have are surgery or injections.
diabetic macular edema
Experimental drug shows promise in preventing diabetic retinal vascular diseases
An experimental drug that had previously demonstrated an ability to slow the growth of liver tumors in mice, has now shown an ability to prevent diabetic retinal vascular disease.